We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
When you invest you want to make money and not lose it. Biggest and quickest way of losing money is chasing things you don't research and jump in. Either you get lucky (infrequent!) or you get stick and lose money by selling low.
I don't look for massive gains but one that can potentially double ot triple in a couple of years but most importantly one where I feel my risk of losing it is low. No guarantees in investment of course.
Exploration is extremely risky but with massive potential rewards. Or new startups are similar as they can fail.
With what I'm seeing with DMTR I see a a real potential of multi bag but one that poses lesser risk of capital wipe out.
They successfully passed their early stage of development and thenn validated their product with industry players. Then moved onto commercial stage and have payinh clients.
They've started to work with big industry players as they validate further and improve it further with integration.
The question of dilution is there. I know Mark said we're funded for 12 months but on Aim if CEOs are approached by city players then they don't say no. But that's not my concern.
A novel digital platform addressing a global multi billion market with major players on side with recurring revenue and at a market cap of 15million with 12months of funding in place.
What's not to like. As always DYOR and best of luck.
Risk assessment of the transaction ! Consider why would a multi billion $ company give a £15 million minnow a tie up with their data ??? Either is just the best product or they think they can integrate and buy dmtr expertise on the cheap !!! Either way looks like we've just turned left :-)
2.4 billion revenue, 40k customers DMTR certainly keep good company, I have a feeling its only a matter of time with this one.
15m mcap company working with multiple multi billion pound companies, they must have something good!
Integrate DigitalGlassware. Just how big is this going to be?
The Company’s newest software technology, UNIFITM, is a scientific information system that is the culmination of a multi-year effort to substantially bring all of Waters’ preexisting, distinct software systems under one operating system. UNIFI joins Waters’ suite of informatics products – EmpowerTM Chromatography Data Software, MassLynxTM Mass Spectrometry Software and NuGenesisTM Scientific Data Management System, each of which is used to support innovations within world-leading institutions. UNIFI is the industry’s first comprehensive software that seamlessly integrates UPLC chromatography, mass spectrometry and informatics data workflows. In 2018, the Company announced new analysis capabilities across a variety of molecules by integrating UNIFI acquired data from the Company’s VionTM IMS QTof or Xevo GS XS mass spectrometers with Molecular Discovery’s Mass-MetaSite and WebMetabase processing software.
The Company has one of the largest direct sales and service organizations focused exclusively on the analytical workflows offered by the Company. Across these product technologies, using respective specialized sales and service workforces, the Company serves its customer base with 56 sales offices throughout the world as of December 31, 2019 and approximately 4,000, 3,900 and 3,800 field representatives in 2019, 2018 and 2017, respectively.
UNIFI Scientific Information System
Waters UNIFI Scientific Information System is the first software platform to merge LC and high performance MS data (both quadrupole and time-of-flight) into a single solution that encompasses data acquisition, processing, visualization, reporting, and configurable compliance tools within a networked laboratory environment.
UNIFI provides organizations the flexibility to deploy UNIFI-based systems within regulated and non-regulated laboratory environments while employing high resolution UPLC separations and high performance mass spectrometry across the entirety of discovery, development, and quality control. And UNIFIs data mining and comparison capabilities enhance your ability to understand results with an unparalleled capability to aggregate and manage data.
Streamline LC-MS Workflows
Laboratory automation is quickly becoming a critical component of the modern lab to streamline pharmaceutical, life science, and analytical LC-MS workflows. Automation of routine and complex sample preparation helps minimize variability, improve traceability, and simplify method transfer. Ultimately bringing improved efficiency to the lab and allowing scientists to increase their productivity.
Cos he fancies u Rid! So cute
sure...but show us the money
more & more are smelling the cashburn
Waters Corporation is a publicly traded Analytical Laboratory instrument and software company headquartered in Milford, Massachusetts. The company employs more than 5,000 people, with manufacturing facilities located in Milford, Taunton, Massachusetts; Wexford, Ireland; Wilmslow,[2] around 13 miles south of Manchester, England; and contract manufacturing in Singapore.Waters markets to the laboratory-dependent organization in these market areas: liquid chromatography, mass spectrometry, supercritical fluid chromatography, laboratory informatics, rheometry and microcalorimetry.majority of the company's revenue is derived from the life science market, a market comprising drug discovery, drug development, quality control, and the emerging sciences of genomics, proteomics and biopharmaceuticals. Waters products are also sold into the food and beverage, environmental, fine chemical, personal care product, university, government, semiconductor, clinical and plastics markets sectors.